Immigration and access to dementia diagnostics and treatment: A nationwide study in SwedenShow others and affiliations
2024 (English)In: SSM - Population Health, ISSN 2352-8273, Vol. 25, article id 101573Article in journal (Refereed) Published
Sustainable development
00. Sustainable Development, 3. Good health and well-being, 10. Reduced inequalities
Place, publisher, year, edition, pages
Elsevier, 2024. Vol. 25, article id 101573
Keywords [en]
Dementia, Diagnosis, Difference, Drug, Ethnic, Inequality, Treatment, angiotensin receptor antagonist, antidepressant agent, anxiolytic agent, beta adrenergic receptor blocking agent, calcium channel blocking agent, cholinesterase inhibitor, dipeptidyl carboxypeptidase inhibitor, diuretic agent, hydroxymethylglutaryl coenzyme A reductase inhibitor, hypnotic agent, memantine, neuroleptic agent, adult, aged, Article, clinical feature, cohort analysis, comparative study, controlled study, ethnicity, female, health care access, health disparity, human, immigration, major clinical study, male, middle aged, observational study, prescription, sensitivity analysis, Sweden, very elderly
National Category
Public Health, Global Health, Social Medicine and Epidemiology
Identifiers
URN: urn:nbn:se:hj:diva-63226DOI: 10.1016/j.ssmph.2023.101573ISI: 001142416200001PubMedID: 38162224Scopus ID: 2-s2.0-85179469304Local ID: HOA;;925172OAI: oai:DiVA.org:hj-63226DiVA, id: diva2:1825266
Funder
Forte, Swedish Research Council for Health, Working Life and Welfare, 2017–01646Stiftelsen Sigurd och Elsa Goljes minneSwedish Society for Medical Research (SSMF)2024-01-092024-01-092024-02-07Bibliographically approved